Financials Professional Medical Expertise Company
Equities
9574
SA15RH24LJ13
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83 SAR | -2.35% | +3.62% | +16.08% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 250.2 |
Enterprise Value (EV) 1 | 313.7 |
P/E ratio | 10.1 x |
Yield | - |
Capitalization / Revenue | 1 x |
EV / Revenue | 1.25 x |
EV / EBITDA | 8.4 x |
EV / FCF | -23,759,014 x |
FCF Yield | -0% |
Price to Book | 2.57 x |
Nbr of stocks (in thousands) | 3,500 |
Reference price 2 | 71.50 |
Announcement Date | 3/31/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 74.42 | 131.3 | 176.1 | 250.1 |
EBITDA 1 | 13.26 | 26.25 | 28.07 | 37.34 |
EBIT 1 | 11.65 | 24.45 | 26.01 | 33.34 |
Operating Margin | 15.65% | 18.63% | 14.77% | 13.33% |
Earnings before Tax (EBT) 1 | 10 | 21.81 | 20.87 | 27.22 |
Net income 1 | 9.296 | 20.62 | 19.02 | 24.84 |
Net margin | 12.49% | 15.71% | 10.8% | 9.93% |
EPS | - | 26.73 | 8.515 | 7.099 |
Free Cash Flow | - | 9.678 | -48.33 | -13.2 |
FCF margin | - | 7.37% | -27.45% | -5.28% |
FCF Conversion (EBITDA) | - | 36.87% | - | - |
FCF Conversion (Net income) | - | 46.94% | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 6/11/23 | 6/11/23 | 6/11/23 | 3/31/24 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 31.4 | 20.1 | 53.2 | 63.4 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | 2.371 x | 0.7649 x | 1.897 x | 1.698 x |
Free Cash Flow | - | 9.68 | -48.3 | -13.2 |
ROE (net income / shareholders' equity) | - | 64.8% | 33.7% | 29.2% |
ROA (Net income/ Total Assets) | - | 10.9% | 8.92% | 8.71% |
Assets 1 | - | 188.9 | 213.1 | 285.3 |
Book Value Per Share | - | 795.0 | 20.90 | 27.80 |
Cash Flow per Share | - | 356.0 | 1.520 | 0.2700 |
Capex 1 | 2.06 | 3.34 | 6.51 | 8.98 |
Capex / Sales | 2.77% | 2.54% | 3.7% | 3.59% |
Announcement Date | 6/11/23 | 6/11/23 | 6/11/23 | 3/31/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+16.08% | 77.45M | |
-5.31% | 181B | |
-5.38% | 99.95B | |
-6.04% | 66.21B | |
+16.45% | 45.4B | |
-8.08% | 45.36B | |
+8.38% | 43.84B | |
+12.06% | 29.03B | |
+17.98% | 25.64B | |
-8.28% | 23.53B |
- Stock Market
- Equities
- 9574 Stock
- Financials Professional Medical Expertise Company